Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait

Mycoses

Volumn 48, Issue 5, 2005, Pages 347-351

  Al Sweih, Noura ^a,b   Ahmad, Suhail ^a   Khan, Zia U ^a   Khan, Seema ^b   Chandy, Rachel ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

Candida dubliniensis; Kuwait; Maternity hospital; Prevalence

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2; RIBOSOME DNA; VORICONAZOLE; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; DNA SEQUENCE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; KUWAIT; MATERNITY WARD; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEQUENCE ANALYSIS; URINALYSIS; VAGINA SMEAR; CANDIDA; CANDIDIASIS; CHEMISTRY; CLASSIFICATION; CULTURE MEDIUM; FEMALE; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; URINE; VAGINA;

CANDIDA; CANDIDA DUBLINIENSIS; FUNGI; HELIANTHUS;

CANDIDA; CANDIDIASIS; CULTURE MEDIA; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, FUNGAL; FEMALE; HOSPITALS, MATERNITY; HUMANS; KUWAIT; MOLECULAR SEQUENCE DATA; PREVALENCE; URINE; VAGINA;

EID: 27744449217     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2005.01143.x     Document Type: Article

References (29)

1. Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002; 3: 207-27.
2. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NA. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144: 829-38.
3. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-76.
4. McGinnis R. Laboratory handbook of Medical Mycology. New York: Academic Press, 1980: 337-410.
5. Khan ZU, Ahmad S, Mokaddas E, Chandy R. Simplified sunflower (Helianthus annuus) seed agar for differentiation of Candida dubliniensis from Candida albicans. Clin Microbiol Infect 2004; 10: 590-2.
6. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman DC. Simple, inexpensive, reliable, method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998; 36: 2093-5.
7. Alves SH, Milan EP, Ana Pde LS, Oliveria LO, Santurio JM, Colombo AL. Hypertonic Sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis 2002; 43: 85-6.
8. Ahmad S, Khan Z, Mustafa AS, Khan ZU. Semi-nested PCR in the diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for identification. J Clin Microbiol 2002; 40: 2483-9.
9. Ahmad S, Mustafa AS, Khan Z, Al-Rifaiy AI, Khan ZU. PCR-enzyme immunoassay of rDNA in the diagnosis of candidemia and comparison with amplicon detection by agarose gel electrophoresis. Int J Med Microbiol 2004; 294: 45-51.
10. Ahmad S, Khan Z, Mokaddas E., Khan ZU. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 2004; 56: 633-7.
11. Fujita SI, Senda Y, Nakaguchi S, Hashimoto T. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol 2001; 39: 3617-22.
12. Gee SF, Joly S, Soll DR et al. Identification of four distinct genotypes of Candida dubliniensis and detection of micro-evolution in vitro and in vivo. J Clin Microbiol 2002; 40: 556-74.
13. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast, Approved Standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
14. National Committee for Clinical Laboratory Standards. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Proposed Guidelines NCCLS Document M44-P. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
15. Kurzai O, Korting HC, Harmsen D et al. Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med 2000; 78: 521-9.
16. Acikgoz ZC, Sancak B, Gamberzade S, Misirlioglu M. Prevalence of Candida dubliniensis among the stored vaginal Candida isolates in a Turkish hospital. Mycoses 2004; 47: 393-6.
17. Ponton J, Ruchel R, Clemons KV et al. Emerging pathogens. Med Mycol 2000; 38 (Suppl. 1): 225-36.
18. Sebti A, Kiehn TE, Perlin D et al. Canada dubliniensis at a cancer center. Clin Infect Dis 2001; 32: 1034-8.
19. Kibbler CC, Seaton S, Barnes RA et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24.
20. Lefler E, McCullough MJ, Clemons KV, Stevens DA. Initial isolation of Candida dubliniensis from the Middle East, Int J Infect Dis 2001; 5: 40-2.
21. Polacheck I, Strahilevitz J, Sullivan D, Donnelly S, Salkin IF, Coleman DC. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000; 38: 170-4.
22. Fotedar R, Al-Hedaithy SS. Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol 2003; 41: 1907-11.
23. Fotedar R, Al Hedaithy SS. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients. Mycoses 2004; 47: 150-5.
24. Al-Hedaithy SS. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses 2003; 46: 293-8.
25. Ruhnke M, Schmidt-Westhausen A, Morschhauser J. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 2000; 46: 291-5.
26. Perea S, Lopez-Ribot JL, Wickes BL et al. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 2002; 46: 1695-703.
27. Al-Mosaid A, Sullivan DJ, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol 2003; 41: 4787-9.
28. McCullough MJ, Jorge JJ, Lejbkowicz F et al. Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area. Mycopathologia 2004; 158: 39-41.
29. Brena S, Rubio Mdel C, Salesa R et al. Genotypes of Candida dubliniensis in clinical isolates. Rev Iberoam Micol 2004; 21: 20-3.